|Bid||0.0870 x 25215400|
|Ask||0.0880 x 5549800|
|Day's range||0.0860 - 0.0890|
|52-week range||0.0800 - 0.2650|
|Beta (5Y monthly)||1.04|
|PE ratio (TTM)||N/A|
|Earnings date||26 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
AdAlta Limited (ASX:1AD) and Carina Biotech Pty Ltd have entered a collaboration agreement to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T cell therapy to treat a far greater range of cancers than the small number of blood cancers that has been achieved today.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...